CSF3 and leukemia: Their studies demonstrates that the usage of G-CSF-primed BM allografts result in a significantly reduced rate of overall cGVHD without losing the graft-versus-leukemia (GVL) effect and approximately considerable OS when compared with G-CSF-mobilized PBSCs.